3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
123
NIH
4
NETWORK
4
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
Azacitidine
4
fludarabine
3
venetoclax
2
bisantrene
2
Cyclophosphamide
2
Clofarabine
2
vosaroxin
1
treosulfan
1
liposomal amphotericin B
1
defactinib
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
cc-486
1
Thalidomide
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Interleukin-2
1
Idarubicin
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Filgrastim
1
Everolimus
1
Dexamethasone
1
Decitabine
1
Daunorubicin
1
Dasatinib
1
Cytarabine
1
Cyclosporine
1
Control Groups
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Leukemia, Myeloid, Acute
×
Mycophenolic Acid
×
Clear all
NCT02416388
2024-08-07
BIG-1
University Hospital, Angers
Phase 2/3
Recruiting
3,100 enrolled